Related Experiment Video
Updated: Jun 17, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Notch-1 inhibition by Withaferin-A: a therapeutic target against colon carcinogenesis
Srinivas Koduru1, Raj Kumar, Sowmyalakshmi Srinivasan
1Department of Clinical Sciences, College of Health Sciences, University of Kentucky, Lexington, Kentucky 40536-0200, USA.
Abstract:
Notch signaling plays a crucial role in the development of colon cancer; targeting the Notch pathway may sensitize colon cancers to various adjuvant agents. The focus of our current study is to identify natural compounds that target Notch signaling and that might be beneficial for the prevention and treatment of colon cancer. Withaferin-A (WA) is a bioactive compound derived from Withania somnifera, which inhibits Notch-1 signaling and downregulates prosurvival pathways, such as Akt/NF-kappaB/Bcl-2, in three colon cancer cell lines (HCT-116, SW-480, and SW-620). In addition, WA downregulated the expression of mammalian target of rapamycin signaling components, pS6K and p4E-BP1, and activated c-Jun-NH(2)-kinase-mediated apoptosis in colon cancer cells. We also established the molecular link between Notch/Akt/mammalian target of rapamycin signaling by complementary approaches (i.e., overexpression of Notch-1 or inhibition of Notch-1 by small interfering RNA). Our results suggest that WA inhibits Notch-mediated prosurvival signaling, which facilitates c-Jun-NH(2)-kinase-mediated apoptosis in colon cancer cell lines. These results underscore the anticancer activity of WA, which exhibits potential for further development for targeted chemotherapy and/or chemoprevention strategies in the context of colon cancer.
Insights
Withaferin-A, a natural compound, inhibits Notch signaling and prosurvival pathways in colon cancer cells. This compound shows potential for developing targeted chemotherapy and chemoprevention strategies for colon cancer.
Area of Science:
- Oncology
- Molecular Biology
- Natural Products Chemistry
Background:
- Notch signaling is integral to colon cancer development.
- Targeting the Notch pathway may enhance colon cancer sensitivity to adjuvant therapies.
- Identifying natural compounds for colon cancer prevention and treatment is a key research area.
Purpose of the Study:
- To investigate natural compounds targeting Notch signaling for colon cancer prevention and treatment.
- To evaluate the efficacy of Withaferin-A (WA) in colon cancer cell lines.
- To elucidate the molecular mechanisms of WA's action on Notch and related signaling pathways.
Main Methods:
- Treatment of colon cancer cell lines (HCT-116, SW-480, SW-620) with Withaferin-A.
- Analysis of Notch-1 signaling, prosurvival pathways (Akt/NF-kappaB/Bcl-2), and mammalian target of rapamycin (mTOR) signaling components (pS6K, p4E-BP1).
- Investigation of apoptosis induction via c-Jun-NH(2)-kinase (JNK) pathway.
- Molecular link establishment using Notch-1 overexpression and small interfering RNA (siRNA) inhibition.
Main Results:
- Withaferin-A inhibited Notch-1 signaling and downregulated prosurvival pathways (Akt/NF-kappaB/Bcl-2) in colon cancer cells.
- WA reduced the expression of mTOR signaling components (pS6K, p4E-BP1).
- Withaferin-A activated c-Jun-NH(2)-kinase-mediated apoptosis and established a molecular link between Notch, Akt, and mTOR signaling.
Conclusions:
- Withaferin-A demonstrates significant anticancer activity by inhibiting Notch-mediated prosurvival signaling in colon cancer.
- WA facilitates c-Jun-NH(2)-kinase-mediated apoptosis in colon cancer cell lines.
- Withaferin-A holds potential for targeted chemotherapy and chemoprevention strategies in colon cancer treatment.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways